Assignee
PIKE THERAPEUTICS INC
CA·5 granted patents·16 pending applications·3 citations·filing 2020–2025
Top patents by PatentIndex Score
21 records- 0184US12016829B2Pharmaceutical composition and method for treating seizure disordersPIKE THERAPEUTICS INC·Filed 2021·Granted Jun 25, 2024·1 cites·4 claims
- 0283US12121617B2Transdermal delivery of cannabidiolPIKE THERAPEUTICS INC·Filed 2021·Granted Oct 22, 2024·1 cites·21 claims
- 0382US12097293B2Transdermal delivery of cannabidiolPIKE THERAPEUTICS INC·Filed 2020·Granted Sep 24, 2024·1 cites·13 claims
- 0475US12268699B2Transdermal delivery of tetrahydrocannabinolPIKE THERAPEUTICS INC·Filed 2024·Granted Apr 8, 2025·0 cites·21 claims
- 0575US2026076921A1Transdermal Pharmaceutical Formulations for the Treatment of Multiple SclerosisPIKE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0673US2024261235A1Pharmaceutical Composition And Method For Treating Seizure DisordersPIKE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0768US2022047541A1Pharmaceutical compositions and methods for treating parkinson's diseasePIKE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0868US2022047525A1Transdermal pharmaceutical formulations of nabilone alone and in combination with cannabinoidsPIKE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0967US2025186363A1Pharmaceutical Compositions and Methods for Treating Parkinson's DiseasePIKE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1066US2025049821A1Pharmaceutical Composition and Method for Treating Seizure DisordersPIKE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1165US2024299372A1Transdermal Drug Delivery Systems for Administration of a Therapeutically Effective Amount of Apixaban and Other Direct Oral AnticoagulantsPIKE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1262US2025248948A1Transdermal and/or Topical, Pharmaceutical Formulations Comprising Cannabidiol and/or Tetrahydrocannabinol for the Treatment of Chronic PainPIKE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1362US2022000794A1Transdermal pharmaceutical formulations for the treatment of multiple sclerosisPIKE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1462US2024024253A1Continuous Drug Delivery Systems and MethodsPIKE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1561US2025312359A1Transdermal Delivery of TetrahydrocannabinolPIKE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1661US2021346310A1Transdermal and/or topical, pharmaceutical formulations comprising cannabidiol and/or tetrahydrocannabinol for the treatment of chronic painPIKE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1759US2023059204A1Transdermal micro-dosing delivery of pharmaceutical agentsPIKE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1857US2022347151A1Transdermal pharmaceutical formulations for the treatment of chronic painPIKE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1955US2022175718A1Transdermal pharmaceutical formulations for the treatment of cancerPIKE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2053US2021322447A1Transdermal micro-dosing delivery of psychedelics derivativesPIKE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2151US12186280B2Pharmaceutical composition and method for treating seizure disordersPIKE THERAPEUTICS INC·Filed 2020·Granted Jan 7, 2025·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when PIKE THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →